// App-Quantinova.ai

: Phylogenetic Analysis of the Epstein Barr Virus Nuclear Antigen-1 and Associated Correlates among Canadian Transplant Patients

Researchers

Presenter

  • M. Abdulnoor

Principal Investigators

  • S. Isabel

  • T. Paton

  • N. Khodai-Booran

  • T. Schechter

  • P. Birk

  • T. Blydt-Hansen

  • B. Foster

  • S. Mital

  • V. Phan

  • S. Urschel

  • G. Casallo

  • T. Papaz

  • L. Hamiwka

  • S. Min

  • U. Allen

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • Montreal University, Montreal, QC, Canada

  • University of Montreal, Montreal, QC, Canada

  • University of Alberta, Edmonton, AB, Canada

  • University of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Post-transplant lymphoproliferative disorder

Biomarkers

  • Epstein–Barr nuclear antigen 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A